Top Markets
#1 Cortex Cortex +173.56%
#2 GEKKO GEKKO +51.79%
#3 ADO Protocol ADO Protocol +18.11%
#4 Helium Helium +15.14%
#5 Audiera Audiera +13.49%
#6 Seeker Seeker +12.81%
#7 Bless Bless +11.68%
#8 o1.exchange o1.exchange +11.17%
#9 aelf aelf +9.98%
#10 Status Status +9.70%
Coin of the day
Cortex Cortex
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rangering i aksjer #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Aksjekurs
$59.98
Sist synkronisert: 2024-12-13
Markedsverdi
$1.22B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Longboard Pharmaceuticals, Inc. (LBPH)

Kategori

Healthcare
Inntekter for Longboard Pharmaceuticals, Inc. (LBPH)
Inntekter i Sep 2024 TTM: $8.00K
Ifølge de nyeste økonomiske rapportene til Longboard Pharmaceuticals, Inc. er selskapets nåværende inntekter (TTM) $8.00K. I 2022 hadde selskapet inntekter på 0.00 lik inntektene i 2021, som var 0.00. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Longboard Pharmaceuticals, Inc. fra 2020 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $8.00K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 157,803,650.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 75,265,991.36%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 196,803,989.28%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 27,849,900.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH